Perrigo | PRGO - Gross Profit On Sales


Perrigo reported $325.5M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AbbVie USD 12.54B 474M Mar/2026
Abbott USD 5.86B 675M Mar/2026
Bayer EUR 6.94B 1.58B Dec/2025
Bristol-Myers Squibb USD 8.41B 381M Dec/2025
Coherus Biosciences USD 8.7M 853K Dec/2025
Corcept Therapeutics USD 162.02M 37.56M Mar/2026
Dr.Reddys Laboratories INR 37.77B 13.6B Mar/2026
Eli Lilly USD 15.92B 1.33B Dec/2025
J&J USD 17.24B 642M Mar/2026
Merck USD 10.85B 2.57B Dec/2025
Nestle CHF 21.43B 174M Dec/2024
Pacira USD 126.64M 15.61M Mar/2026
Perrigo USD 325.5M 36.7M Mar/2026
Pfizer USD 11.04B 1.24B Mar/2026
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Prestige Brands USD 157.37M 5.79M Dec/2025
Reckitt Benckiser GBP 4.25B 2.08B Dec/2024
Sanofi EUR 8.45B 1.31B Dec/2025
Supernus Pharmaceuticals USD 129.36M 34.68M Mar/2026
Teva Pharmaceutical Industries USD 2.11B 547M Mar/2026
Xeris Pharmaceuticals USD 72.15M 8.77M Dec/2025
Zoetis USD 1.62B 20M Mar/2026